Loading fund overlap…
8 of 142 unique stocks in common · Jaccard: 5.6%
A weighted portfolio overlap of 5.59% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹5.59 is allocated to the exact same companies at the same relative proportions. The schemes share 8 common holdings.
The largest overlapping asset in their portfolios is Mankind Pharma, which commands a weight of 2.37% in Back to Index and 1.10% in Nippon India Flexi Cap Fund. Holding both schemes increases your concentration in Mankind Pharma rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Back | in Nippon |
|---|---|---|
| Mankind PharmaPharmaceuticals & Biotechnology | 2.37% | 1.10% |
| Gland PharmaPharmaceuticals & Biotechnology | 1.31% | 0.95% |
| DelhiveryTransport Services | 2.42% | 0.84% |
| JSW InfrastructureTransport Infrastructure | 0.81% | 1.20% |
| Bharti HexacomTelecom - Services | 1.07% | 0.77% |
| Devyani InternationalLeisure Services | 0.48% | 1.49% |
| Kaynes Technology IndiaIndustrial Manufacturing | 1.20% | 0.33% |
| One 97 CommunicationsFinancial Technology (Fintech) | 4.31% | 0.31% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on Apr 2026). Equity holdings only, ISIN-verified. Not investment advice.